Myopia, Hyperopia, Astigmatism, Photorefractive keratectomy.
Conditions
Interventions
Intervention 1: Intervention group: In addition to the nonsteroidal anti-inflammatory drug Novafen, 1 tablet every 8 hours for 3 days after surgery from Razek Pharmaceutical Company, they will receive
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age over 18 years and under 65 years Consent to participate in the study
Exclusion criteria
Exclusion criteria: Having a history of mental illness Presence of stomach ulcers and pud Addiction Unwillingness to participate in the study History of diabetes Corticosteroid use within the last month History of benzodiazepine and tricyclic drug use within the last two weeks Alcohol abuse History of obstructive sleep apnea Myasthenia gravis History of liver disease History of severe respiratory failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain levels of patients after Photorefractive keratectomy surgery. Timepoint: Pain levels of patients after Photorefractive keratectomy surgery at 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determining and comparing complications in the two intervention and control groups. Timepoint: Determination and comparison of complications in the intervention and control groups 12 and 24 hours after surgery. Method of measurement: Questions on the day after surgery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Khajavi Ghare Mirshamloo
Zahedan University of Medical Sciences
Outcome results
None listed